LABS - Surat Pengantar LK Q1_ 01_018.pdf

UBC Medical
Indonesia

Jakarta, 28 April 2026
No.: 01.018/CS-MM/LABS/IV/26

Kepada Yth.:

Direktur Penilaian Keuangan Perusahaan
Sektor Riil Otoritas Jasa Keuangan

Gedung Soemitro Djojohadikusumo Lantai 4
Jalan Lapangan Banteng Timur No. 2-4 Jakarta
10710

Perihal:

Penyampaian Laporan Keuangan Konsolidasian
Kuartal 1-1 2026 (Unaudited) PT UBC Medical
Indonesia Tbk

Dengan hormat,

Berdasarkan Peraturan Otoritas Jasa Keuangan
Nomor 7/POJK.04/2018 Tentang Penyampaian
Laporan Melalui Sistem Pelaporan Elektronik
Emiten Atau Perusahaan Publik, maka bersama
surat ini kami sampaikan (soft copy) Laporan
Keuangan Konsolidasian per tanggal 30 Maret
2026 (unaudited).

Demikian kami sampaikan. Atas perhatiannya
kami ucapkan terima kasih.

Jakarta, 28 April 2026
No.: 01.018/CS-MM/LABS/IV/26

To:

Director of Financial Assessment of Real Sector
Companies, Financial Services Authority
Sumitro Djojohadikusumo Building

Ministry of Finance of the Republic of Indonesia
Jl. Lapangan Banteng Timur No. 1-4

Jakarta 10710

Subject:

Submission of Consolidated Financial
Statements as 1" Ouarter-A1, 2026
(Unaudited) of PT UBC Medical Indonesia Tbk

With due respect,

Based on Financial Services Authority Regulation
Number 7/POJK.04/2018 Concerning Submission
of Reports Through the Electronic Reporting
System of Issuers or Public Companies, we
hereby submit soft copy of the Consolidated
Financial Report as of March 30, 2026
(unaudited)..

Thus we convey. Thank you for your attention.

PT UBC MEDICAL INDONESIA Tbk

E.X Yoshua Raintjun,
Direktur Utama/President Director

Head Office :

Kawasan Industri Pulogadung

Jl. Rawa Gelam V, Blok. L, Kav.11-13
Jakarta - 13930

(021) 3886510
: . P

www.ubcindonesia.com